Crossmark

SIRT1 and FOXO1 role on MASLD risk: effects of DHA-rich n-3 PUFA supplementation and exercise in aged obese female mice and in post-menopausal overweight/obese women

Crossref DOI link: https://doi.org/10.1007/s13105-024-01044-9

Published Online: 2024-09-12

Published Print: 2024-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Jinchunzi https://orcid.org/0000-0002-8519-2878
Félix-Soriano, Elisa https://orcid.org/0000-0003-4633-1289
Martínez-Gayo, Alejandro

Ibañez-Santos, Javier

Sáinz, Neira https://orcid.org/0000-0003-0298-3031
Martínez, J Alfredo https://orcid.org/0000-0001-5218-6941
Moreno-Aliaga, María J. https://orcid.org/0000-0002-2018-6434
Funding

Funding for this research was provided by:

Ministerio de Ciencia e Innovación (BFU2015-65937-R)

CIBER Fisiopatología de la Obesidad y la Nutrición, ISCIII (CIBEROBN (CB12/03/30002))

Ministerio de Universidades (FPU17/02789)

Universidad de Navarra
License Information

Text and Data Mining valid from 2024-08-01

Version of Record valid from 2024-09-12
More Information

Article History

Received: 21 November 2023

Accepted: 7 August 2024

First Online: 12 September 2024

Declarations

:

: The animal study was approved by the Ethics Committee for Animal Experimentation of the University of Navarra (protocol no. 113–15), and performed in accordance with national and EU guidelines for the handling and use of experimental animals. The human intervention was approved by the Research Ethics Committee of the University of Navarra (140/2015mod1 and 2015.140mod2) and was performed in compliance with the Helsinki Declaration guidelines. The study was registered at clinicaltrials.gov as NCT03300388.

: The authors declare no competing interest concerning this research.

Document is current

Any future updates will be listed below